Here are the week's hottest stories from Wealth Daily and our sister site, Energy and Capital. Here are the week's hottest stories from Wealth Daily and our sister site, Energy and Capital. [Wealth Daily logo] What Happens to Ukraine Matters for You [Jason Williams Photo] By [Jason Williams](
Written Feb 26, 2022 In case you missed it, we've compiled the week's hottest stories from [Wealth Daily]( and our sister site, [Energy and Capital](… [Hey! Do You Want to Split This Loot With Me?](
Jason Williams has an offer he hopes you can't refuse. He wants to split a massive payout coming next month with YOU! Here's what Jason has to say... [Biggest EV Play Since Tesla](
There's a little-known segment of the electric vehicle (EV) industry that's on the verge of incredible growth — a level of growth that could easily surpass Tesla's gains... And there's one stock that's at the center of all it all. Get the details here. [A Brief History of a Plague](
After 25 years of intense research, mRNA vaccines have finally been released to the public — and Moderna just started clinical trials for its mRNA HIV vaccine. [How to Return America to Dominance](
America used to be a leader in microchip manufacturing, but somehow it shifted to depending almost entirely on a handful of companies in Asia, which has been one of the biggest reasons behind America's current supply chain issues. The government realized that it needs to bring chip production back home, and this is how it plans to do it... [Tesla 2.0, and Why You're Probably Going to Miss Out](
Tesla 2.0 will not be a supercar. You won't be drooling over it, and your kids won't beg you to take them for a ride. That doesn't mean the revolution won't happen. The #1 Strategy for Biotech Stocks? It’s no secret that biotech is the most exciting investment arena there is. There’s never a shortage of demand for new treatments for the world’s worst diseases, like cancer, Alzheimer’s, and arthritis. And with my new trading system, “Project Greenlight,” you’ll always know with up to 95% confidence which of those new medicines will be approved by the FDA and which won’t... This could set investors up to make six figures or more in biotech profits. And right now, there's a tiny biotech firm trading for pennies on the dollar with a medicine that’s on the brink of FDA approval... [Learn more about this unique opportunity today.]( [Here's Why Ukraine Matters to You](
Ukraine is rich with natural resources that make its land economically viable, which is just one reason why Russia remains focused on the country. With that being said, it's important to pay attention to what's going on between Ukraine and Russia because it demonstrates the need to find energy alternatives so that one country can't have political leverage over others by withholding or gauging prices of natural resources like gas and lithium. Here's a glimpse of how one company is proving it can be done... [Pentagon Just Named This Chipmaker Its New "Trusted Supplier"](
In many ways, the plan to make America No. 1 in semiconductor production has already begun. These are the chip stocks that will see the most growth... [Can You Trust Warren Buffett?](
The world's most famous buy-and-hold investor has finally thrown in the towel in his crusade against cryptocurrency and bought $1 billion worth of stock in a digital bank whose main focus is crypto. Of course, I always knew the crypto market was going to be massive, so I kept my focus on a group of cryptocurrencies, and now that group is poised to create once-in-a-lifetime gains for its early investors. [Supervolcanoes and Oregon's Trillion-Dollar Secret](
The most important mineral on Earth is in the Pacific Northwest. Oregon is looking at a trillion-dollar opportunity here — but it won't be easy. Here's why... [Why 7 Billionaires Are Piling Into This Stock](
Thanks to a new battery technology, EVs may cost the same as gas-powered cars — by next year… and one company that pioneered this new technology could offer the investment of a lifetime. It has already attracted seven billionaire investors… The technology is protected by 200 patents… and is expected to trigger a 1,500% surge in EV sales over the next four years. See if this stock is a good fit for your portfolio. To your wealth, [jason-williams-signature-transparent] Jason Williams [[follow basic] @TheReal_JayDubs]( [[follow basic]The Wealth Advisory on Youtube]( [[follow basic]The Wealth Advisory on Facebook]( After graduating Cum Laude in finance and economics, Jason designed and analyzed complex projects for the U.S. Army. He made the jump to the private sector as an investment banking analyst at Morgan Stanley, where he eventually led his own team responsible for billions of dollars in daily trading. Jason left Wall Street to found his own investment office and now shares the strategies he used and the network he built with you. Jason is the founder of [Main Street Ventures](, a pre-IPO investment newsletter, and co-authors [The Wealth Advisory]( income stock newsletter. He also contributes regularly to [Wealth Daily](. To learn more about Jason, [click here](. Browse Our Archives [Something's Happening Here](
[A Brief History of a Plague](
[Should You Be Scared of AI?](
[Hey! Do You Want to Split This Loot With Me?](
[Tesla 2.0, and Why You're Probably Going to Miss Out](
--------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here]( and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Wealth Daily, please add newsletter@wealthdaily.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. Wealth Daily, Copyright © 2022, Angel Publishing LLC. All rights reserved. 3 E Read Street, Baltimore, MD 21202. Your privacy is important to us – we will never rent or sell your e-mail or personal information. Please read our [Privacy Policy](. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment advice. Read our [Details and Disclosures.]( ---------------------------------------------------------------